自主可控
Search documents
这只浮动费率基金定位“成长共赢”,值得买吗?
市值风云· 2025-06-11 10:06
Core Viewpoint - The article emphasizes the importance of identifying growth opportunities in changing economic landscapes, highlighting the role of Jiashi Fund in capitalizing on emerging industries and trends [2][25]. Group 1: Historical Industry Trends - From 2013 to 2015, China experienced a shift from PC internet to mobile internet, with mobile internet users increasing from 810 million to 960 million, and the internet market size growing from 99.15 billion to 175.03 billion yuan [3][6]. - The TMT (Technology, Media, and Telecommunications) sector saw significant revenue and net profit growth during this period, with electronics revenue growth rates of 20.19%, 19.64%, and 14.49% from 2013 to 2015 [7]. - Jiashi Fund's active equity funds achieved an average return of 97.1% during the "Internet Plus" cycle, with notable funds like Jiashi Leading Growth Mixed and Jiashi Growth Income Mixed yielding returns of 170.3% and 154.1% respectively [9]. Group 2: Recent Industry Developments - The period from 2019 to 2021 marked explosive growth in high-end manufacturing and biotechnology, with semiconductor and new energy sectors experiencing significant policy support and market expansion [12][14]. - The semiconductor sector saw some sub-sectors, like analog chip design, increase by over 1,000% during this time [13]. - Jiashi Fund recorded an average return of 120.1% across 65 actively managed funds during this period, successfully capturing opportunities in semiconductors, electric vehicles, and photovoltaics [19]. Group 3: Current and Future Opportunities - Since 2023, the focus has shifted towards self-sufficiency in high-tech industries, with significant growth opportunities in sectors like semiconductors, AI, and smart driving [22]. - Jiashi Fund has proactively established research teams to track AI industry changes and has launched products like the Sci-Tech Chip ETF to capitalize on these trends [23]. - The newly launched Jiashi Growth Co-Winning Mixed Fund aims to leverage growth opportunities in the Chinese economy, with a focus on technology sectors such as power equipment, electronics, and automotive [29][31]. Group 4: Fund Structure and Management - The Jiashi Growth Co-Winning Mixed Fund employs a floating fee structure, aligning the interests of fund managers with investors by adjusting management fees based on performance [26][40]. - The fund's investment strategy is anchored in the CSI 800 Growth Index, which focuses on high-growth sectors while maintaining a diversified portfolio [28][29]. - The fund manager, Li Tao, has a strong background in technology and has demonstrated successful performance in managing funds focused on information technology and related sectors [35][38].
逆市买入,半导体ETF(159813)盘中申购超1.3亿份
Xin Lang Cai Jing· 2025-06-11 06:20
Group 1 - The TMT sector experienced a broad pullback, with the semiconductor sector showing sideways fluctuations due to several core factors [1] - The merger of Haiguang Information and Zhongke Shuguang did not meet market expectations, impacting market sentiment [1] - Apple's WWDC event fell short of expectations, particularly in AI terminal innovation, leading to weaker replacement demand in certain regional markets [1] - Ongoing US-China tariff negotiations in London may affect the direction of self-controllable entities, as the US is willing to lift export restrictions in exchange for China easing rare earth export limits [1] Group 2 - Despite external challenges, the logic of self-controllability is becoming inevitable, driven by long-term national policy planning and top-level design emphasizing modern industrial system construction [2] - The domestic supply chain may see improvements in performance due to potential supply gaps in goods heavily reliant on US imports, as Chinese countermeasures could raise import prices [2] Group 3 - Related products include semiconductor ETFs and various mutual funds [3] - Key stocks in the semiconductor sector include SMIC, Haiguang Information, and several others [3]
EDA海外供应风险提升,机构称国产EDA加速崛起
Mei Ri Jing Ji Xin Wen· 2025-06-11 02:24
Group 1 - A-shares opened higher and continued to rise, with major indices showing gains, particularly in non-bank financials, automotive, power equipment, non-ferrous metals, and agriculture sectors [1] - The recent surge in the self-controlled theme is reflected in the performance of ETFs, with the Xinchuang ETF (562570) rising nearly 0.5% and the Sci-Tech Semiconductor ETF (588170) increasing over 1% [1] - EDA (Electronic Design Automation) tools are crucial for the integrated circuit industry, serving as a strategic foundation across the entire industry chain, which includes process platform development, integrated circuit design, and manufacturing [1] Group 2 - The EDA industry is experiencing significant growth, driven by advancements in AI, cloud computing, and system integration, amidst rising design costs due to advanced processes [1] - Domestic EDA companies are innovating and collaborating to overcome challenges posed by the expiration of foreign EDA product licenses and increasing industry cooperation, supported by national policies [1] - The Xinchuang ETF (562570) tracks the CSI Information Technology Application Innovation Industry Index, focusing on domestic alternatives and covering cutting-edge sectors such as AI, data computing, industrial software, and information security [2]
券商晨会精华:以轮动思维来博弈科技行情
Xin Lang Cai Jing· 2025-06-11 00:30
Group 1 - The market experienced a rapid decline in the afternoon, with the ChiNext Index leading the drop, and the total trading volume in Shanghai and Shenzhen reaching 1.42 trillion, an increase of 129 billion compared to the previous trading day [1] - Sectors such as port shipping, beauty care, innovative drugs, and rare earth permanent magnets saw significant gains, while sectors like Huawei Ascend, military industry, semiconductors, and software development faced declines [1] - As of the market close, the Shanghai Composite Index fell by 0.44%, the Shenzhen Component Index dropped by 0.86%, and the ChiNext Index decreased by 1.17% [1] Group 2 - Huatai Securities' 2025 mid-term outlook emphasizes the importance of the AI technology revolution, military industry, and self-sufficiency amid global order restructuring and changing asset pricing dynamics [2] - The report highlights the need for flexibility in asset operations, suggesting to leverage high odds and low correlation strategies to navigate the uncertain environment [2] - It also notes that the weakening trend of the US dollar may favor non-US assets, with European assets showing higher success rates and emerging markets like Hong Kong offering better odds [2] Group 3 - CICC indicates that the tungsten market is entering a bull market phase, driven by tightening supply and demand dynamics, along with overseas premium pricing for tungsten products [3] - The long-term outlook predicts that the tungsten supply-demand gap will expand from 18,300 tons in January 2024 to 19,100 tons by 2028, with the supply-demand gap as a percentage of original tungsten demand projected to be negative over the years [3] Group 4 - Huaxi Securities suggests adopting a rotation strategy to capitalize on the technology sector's rebound, driven by improved expectations regarding US-China trade relations [4] - The report warns of ongoing uncertainties in international cues, indicating the need for preparedness against market fluctuations and avoiding excessive trading in a single direction [4] - It emphasizes that if the technology sector faces significant corrections, it may present better opportunities for recovery, particularly for the Sci-Tech 50 index [4]
聚光科技(300203):科研仪器龙头企业 利润端有望迎来快速释放
Xin Lang Cai Jing· 2025-06-10 10:39
Core Viewpoint - The company, as a leader in the domestic scientific instrument industry, is facing significant development opportunities under the national push for self-control and domestic substitution. With the deepening of relevant support policies and the gradual release of equipment renewal demand in downstream industries, the company is expected to achieve rapid growth in order acquisition and revenue conversion in the scientific instrument field by 2025 [1][5][10] Financial Performance - In 2024, the company achieved revenue of 3.614 billion yuan, a year-on-year increase of 13.58%, and a net profit attributable to shareholders of 207 million yuan, a year-on-year increase of 164.11%. The non-recurring net profit attributable to shareholders was 127 million yuan, a year-on-year increase of 132.82% [1][3] - For Q1 2025, the company reported revenue of 547 million yuan, a year-on-year increase of 1.38%, and a net profit attributable to shareholders of -21 million yuan, a year-on-year increase of 18.77% [1][4] Business Strategy - The company is focusing on core businesses such as scientific instruments, life science instruments, and industrial analysis instruments, while appropriately reducing long-term R&D layouts and non-high-end analysis instrument businesses. This strategy has led to a significant turnaround in profitability [3][10] - The company has established four business units targeting clinical research and early disease diagnosis, indicating a proactive approach to expanding into the life sciences sector [7] Operational Efficiency - The overall gross margin for 2024 was 44.43%, an increase of 3.17 percentage points year-on-year. The company has effectively controlled expenses, with a sales expense ratio of approximately 16.67%, a decrease of about 4.21 percentage points [8][9] - The net cash flow from operating activities for 2024 was 688 million yuan, a year-on-year increase of 152.34%, reflecting improved operational quality [8] Future Outlook - The company is expected to benefit from the acceleration of local government debt reduction and the gradual alleviation of the negative impact of PPP projects on overall performance. This is anticipated to support the company's performance recovery [5][6][10] - Projections for 2025-2027 indicate expected revenues of 4.066 billion, 4.538 billion, and 5.039 billion yuan, with corresponding net profits of 320 million, 439 million, and 589 million yuan, reflecting a strong growth trajectory [11]
聚链成势 科创板“硬科技”集群擎起自立自强 “大旗”
Zheng Quan Shi Bao Wang· 2025-06-10 09:41
Group 1: Strategic Emerging Industries Development - The government work report emphasizes the promotion of integrated cluster development in strategic emerging industries, highlighting the formation of substantial industrial clusters in the Sci-Tech Innovation Board [1] - The Sci-Tech Innovation Board has 113 listed companies in the biopharmaceutical sector, focusing on treatments for cancer, AIDS, and hepatitis B, making it a major listing venue globally outside the US and Hong Kong [1] - In the integrated circuit sector, there are 119 companies, representing a significant portion of A-share listed companies, with a complete industrial chain from chip design to packaging and testing [1] Group 2: Biopharmaceutical Sector Innovations - The National Medical Products Administration approved 11 new drugs, with five from Sci-Tech Innovation Board companies, indicating a strong performance in drug innovation [2] - Eight new drugs have been approved for Sci-Tech Innovation Board innovative drug companies this year, with a total of 33 globally new class 1 drugs launched since 2018, accounting for 14% of domestic approvals [2] - The medical device sector has seen increased domestic production rates for high-end imaging equipment, with companies establishing resilient supply chains [2] Group 3: Integrated Circuit Industry Growth - The integrated circuit sector reported a net profit of 4.479 billion yuan in Q1, a 73% year-on-year increase, driven by domestic substitution and demand recovery [4] - Companies in the chip design and semiconductor equipment sectors have shown significant revenue and profit growth, with some companies like Hengxuan Technology achieving a 590.22% increase in net profit [4][5] - The production capacity and order status of wafer manufacturing companies remain strong, with major players like SMIC and Huahong maintaining high utilization rates [5] Group 4: Strategic Expansion and Internationalization - Companies in the Sci-Tech Innovation Board are exploring mergers and acquisitions to achieve external growth, with recent announcements of mergers such as Haiguang Information and Zhongke Shuguang [6] - The internationalization of biopharmaceutical companies is accelerating, with 11 companies granting overseas rights to their innovative drugs, marking a significant step towards global market entry [7] - The collaboration between domestic companies and global research institutions is increasing, with over 55 top research institutions engaged in partnerships, facilitating the global transformation of innovative results [7]
信创ETF易方达(159540)连续10日获资金净流入,重磅合并落地,信创板块景气度有望持续上行
Xin Lang Cai Jing· 2025-06-10 08:12
Group 1 - The core viewpoint of the news highlights the active trading and significant inflow of funds into the Xinchang ETF managed by E Fund, indicating strong market interest and performance [1] - As of June 9, the Xinchang ETF has reached a new high in scale at 709 million yuan and a total of 590 million shares, reflecting robust growth since its inception [1] - The Xinchang ETF has seen a continuous net inflow of funds totaling 545 million yuan over the past 10 days, showcasing its attractiveness to investors [1] Group 2 - The announcement of a major asset restructuring by Haiguang Information, which plans to issue A-shares to exchange for shares held by all shareholders of Zhongke Shuguang, marks a significant development in the domestic computing sector [1] - The exchange price for the absorbing party is set at 143.46 yuan per share, while the absorbed party's price is 79.26 yuan per share, indicating a strategic valuation in the merger [1] - Tianfeng Securities emphasizes that the ongoing economic negotiations and the focus on self-sufficiency remain a long-term logic, with the Xinchang sector expected to benefit from policy support and technological advancements [1]
受益于政策支持自主可控与技术迭代,信创板块景气度有望持续上行
Mei Ri Jing Ji Xin Wen· 2025-06-10 02:02
6月10日早盘,A股银行股继续走强,南京市国资、固态电池、动力电池、CRO、仿制药等概念指数盘 中活跃。近期备受资金关注的信创ETF(562570)开盘后一度跌超2%,持仓股跌多涨少,概伦电子、 深信服、用友网络、泛微网络等跌幅居前,换股吸收合并预案出炉,中科曙光复牌一字涨停。 据悉,信创ETF(562570)跟踪中证信息技术应用创新产业指数。该指数聚焦新质生产力,布局自主可 控头部公司,覆盖人工智能、数据算力、工业软件、信息安全等前沿科创产业。截至6月9日,指数前十 大权重股分别为浪潮信息、海光信息、华大九天、深信服、金山办公、用友网络、恒生电子、中科曙 光、广联达、三六零,合计权重47.72%。信创ETF(562570)为跟踪该指数规模最大的ETF。截至6月9 日,信创ETF(562570)自5月16日以来已连续16个交易日获资金净流入,合计净流入金额高达22.78亿 元。 天风证券指出,经贸协商未完待续,自主可控仍是长期逻辑。自主可控的第一个逻辑是国家政策多年布 局下的积累;自主可控的第二个逻辑是国产替代。穿透到二级行业,短期可以关注估值处于低位的方 向,中期关注产业节奏。估值方面,前期估值处于低位的板 ...
两大千亿龙头,重组预案出炉!细节曝光
21世纪经济报道· 2025-06-09 15:06
Core Viewpoint - The merger proposal between Haiguang Information and Zhongke Shuguang aims to create a comprehensive integration of resources in the domestic information industry, enhancing competitiveness in the computing power sector and aligning with national strategies for self-sufficiency in technology [1][2]. Group 1: Merger Details - Haiguang Information plans to absorb Zhongke Shuguang through a share exchange ratio of 0.5525:1, meaning each share of Zhongke Shuguang will be exchanged for 0.5525 shares of Haiguang Information [2]. - The merger will allow Haiguang Information to inherit all assets, liabilities, and rights of Zhongke Shuguang, with Zhongke Shuguang's listing being terminated post-merger [1]. Group 2: Strategic Implications - The merger is expected to create a synergy between Haiguang Information's strengths in chip design and Zhongke Shuguang's expertise in high-end computing and data center infrastructure, promoting technological breakthroughs and enhancing supply chain resilience [1][2]. - This transaction marks the first absorption merger following the revision of the "Major Asset Restructuring Management Measures" on May 16, indicating a significant step in the consolidation of the computing power industry in China [2]. Group 3: Market Impact - Analysts believe that the merger will enhance the overall competitiveness of domestic computing power and align with the national strategy for self-sufficiency, potentially leading to increased attention on technology and merger integration in the market [2][3]. - The merger is anticipated to accelerate the application of domestic chips across various sectors, including government, communication, finance, and energy, thereby promoting healthy development in the information industry [3].
高盛、摩根士丹利继续看多,外资机构力挺中国资产
2 1 Shi Ji Jing Ji Bao Dao· 2025-06-09 12:23
Group 1 - Several foreign institutions have raised their GDP growth forecasts for China in 2025, indicating a growing optimism towards Chinese assets [1][8][11] - Morgan Stanley, Deutsche Bank, and others have expressed bullish sentiments on Chinese stocks, with Morgan Stanley's mid-year outlook predicting increases in major indices [1][4][5] - High demand for Chinese assets is driven by a stronger RMB against the USD, improved corporate earnings outlook, and anticipated foreign capital inflows [5][6] Group 2 - Foreign institutions are focusing on two main sectors: technology and internet leaders, and high-dividend strategies to hedge against volatility [6][7] - The trend of overweighting Chinese assets has been noted, with Standard Chartered and HSBC highlighting the importance of diversifying investments in Asia [7] - Recent adjustments in GDP growth forecasts reflect a broader expectation of economic improvement, supported by policy measures and potential fiscal stimulus [8][9][11]